Comparative analysis of Nε-carboxymethyl-lysine and inflammatory markers in diabetic and non-diabetic coronary artery disease patients

Table 5 Correlation analysis of Nε-carboxymethyl-lysine with inflammatory markers, nitric oxide, Gensini score, and biochemical parameters

Parameter	Subcategory	Combined (group I and group II)		Group I		Group II
		Correlation coefficient	P value	Correlation coefficient	P value	Correlation coefficient	P value
CML	Gensini score	0.193	0.006	0.056	0.577	0.353	0.001
	IL-6	0.596	0.001	0.502	0.001	0.673	0.001
	TNF-α	0.337	0.001	0.256	0.01	0.436	0.001
	Nitric oxide	-0.416	0.001	-0.484	0.001	-0.283	0.004
	TC	0.216	0.002	0.25	0.01	0.109	0.281
	Triglycerides	0.156	0.027	0.087	0.389	0.169	0.093
	HDL-C	-0.064	0.372	-0.105	0.298	0.006	0.953
	LDL-C	0.251	0.001	0.289	0.003	0.151	0.134
	VLDL-C	0.131	0.065	0.045	0.654	0.176	0.081
	Random blood sugar	-0.011	0.875	-0.204	0.052	0.081	0.43
	HbA1c	0.14	0.048	0.006	0.951	0.044	0.66
	Urea	-0.004	0.953	-0.006	0.957	-0.046	0.653
	Creatinine	0.059	0.405	0.129	0.202	-0.047	0.646
	Total bilirubin	0.053	0.458	0.083	0.413	0.08	0.428
	Total protein	0.086	0.229	0.183	0.07	-0.055	0.585
	Albumin	0.062	0.387	0.201	0.046	-0.064	0.525
	Alkaline phosphatase	0.042	0.556	0.003	0.975	0.033	0.743
	SGOT	-0.061	0.395	-0.056	0.581	-0.032	0.754
	SGPT	0.019	0.793	0.102	0.317	-0.027	0.788
	Sodium	0.022	0.762	0.059	0.559	0.079	0.432
	Potassium	0.116	0.103	0.076	0.452	0.102	0.313
	Duration of diabetes	-	-	0.494	0.001	-	-

Group I: Diabetic coronary artery disease patients; Group II: Non-diabetic coronary artery disease patients. CML: Nε-carboxymethyl-lysine; HbA1c: Glycosylated hemoglobin; HDL-C: High-density lipoprotein cholesterol; IL-6: Interleukin 6; LDL-C: Low-density lipoprotein cholesterol; SGOT: Glutamic-oxalacetic transaminase; SGPT: Glutamic-pyruvic transaminase; TC: Total cholesterol; TNF-α: Tumor necrosis factor-alpha; VLDL-C: Very low-density lipoprotein cholesterol.